Sign inSign in
ConceptMedicine

Onasemnogene abeparvovec-xioi (Zolgensma)

A gene replacement therapy utilizing an adeno-associated virus serotype 9 vector to deliver the SMN1 gene for the treatment of all types of spinal muscular atrophy in patients under two years of age.
as Amanda Rogers defines itUniversity of Louisville
Watch it explained

Know first

Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.

Adeno-associated virus vectors1Gene therapy1Spinal muscular atrophy1

Lecturers

1

    Connections

    3

    The lectures that define it or assume it, and the concepts next to it.

    Concepts2

    1 lecturer. Definitions are written by AI from each lecture’s transcript. A time with a play mark starts the lecture at the moment the lecturer says it.